The first stage of the manufacturing of Joel’s personalised vaccine has now been completed. This is the extraction of antigens, (cancer proteins), from Joel’s original tumour tissue, which was transported from Salford Royal Hospital to the biotech company in Cambridge. The next stage is to introduce Joel’s white blood cells, (his ‘immunity cells’), to the antigens to start to cultivate natural antibodies.
This will take place mid-January 2021, followed by the delivery of the vaccine at King’s Hospital London. All being well, Joel will be back in London to resume his English degree course at King’s College in the new year. So, it should all be convenient for him.
Thanks again for all of your support and please continue to help us to HelpJoelLiveLonger.
Ian, Steph and Joel X
This crowdfunding campaign has been set up by a small group on behalf of our much loved friends Steph and Ian, in the hope that together we can extend the life of their 19 year old son, Joel. https://www.gofundme.com/f/helpjoellivelonger/share